240 related articles for article (PubMed ID: 33649828)
21. Hyaluronan facilitates transforming growth factor-β1-dependent proliferation via CD44 and epidermal growth factor receptor interaction.
Meran S; Luo DD; Simpson R; Martin J; Wells A; Steadman R; Phillips AO
J Biol Chem; 2011 May; 286(20):17618-30. PubMed ID: 21454519
[TBL] [Abstract][Full Text] [Related]
22. Increase in hyaluronic acid degradation decreases the expression of estrogen receptor alpha in MCF7 breast cancer cell line.
Hanoux V; Eguida J; Fleurot E; Levallet J; Bonnamy PJ
Mol Cell Endocrinol; 2018 Nov; 476():185-197. PubMed ID: 29753772
[TBL] [Abstract][Full Text] [Related]
23. CD44v10 interaction with Rho-kinase (ROK) activates inositol 1,4,5-triphosphate (IP3) receptor-mediated Ca2+ signaling during hyaluronan (HA)-induced endothelial cell migration.
Singleton PA; Bourguignon LY
Cell Motil Cytoskeleton; 2002 Dec; 53(4):293-316. PubMed ID: 12378540
[TBL] [Abstract][Full Text] [Related]
24. Cellular heterogeneity profiling by hyaluronan probes reveals an invasive but slow-growing breast tumor subset.
Veiseh M; Kwon DH; Borowsky AD; Tolg C; Leong HS; Lewis JD; Turley EA; Bissell MJ
Proc Natl Acad Sci U S A; 2014 Apr; 111(17):E1731-9. PubMed ID: 24733940
[TBL] [Abstract][Full Text] [Related]
25. Hyaluronan-CD44 interaction with protein kinase C(epsilon) promotes oncogenic signaling by the stem cell marker Nanog and the Production of microRNA-21, leading to down-regulation of the tumor suppressor protein PDCD4, anti-apoptosis, and chemotherapy resistance in breast tumor cells.
Bourguignon LY; Spevak CC; Wong G; Xia W; Gilad E
J Biol Chem; 2009 Sep; 284(39):26533-46. PubMed ID: 19633292
[TBL] [Abstract][Full Text] [Related]
26. Hyaluronan size alters chondrogenesis of adipose-derived stem cells via the CD44/ERK/SOX-9 pathway.
Wu SC; Chen CH; Wang JY; Lin YS; Chang JK; Ho ML
Acta Biomater; 2018 Jan; 66():224-237. PubMed ID: 29128538
[TBL] [Abstract][Full Text] [Related]
27. Adhesion glycoprotein CD44 functions as an upstream regulator of a network connecting ERK, AKT and Hippo-YAP pathways in cancer progression.
Yu S; Cai X; Wu C; Wu L; Wang Y; Liu Y; Yu Z; Qin S; Ma F; Thiery JP; Chen L
Oncotarget; 2015 Feb; 6(5):2951-65. PubMed ID: 25605020
[TBL] [Abstract][Full Text] [Related]
28. CD44/HA signaling mediates acquired resistance to a PI3Kα inhibitor.
Yang C; Sheng Y; Shi X; Liu Y; He Y; Du Y; Zhang G; Gao F
Cell Death Dis; 2020 Oct; 11(10):831. PubMed ID: 33024087
[TBL] [Abstract][Full Text] [Related]
29. Oligosaccharides of hyaluronan induce angiogenesis through distinct CD44 and RHAMM-mediated signalling pathways involving Cdc2 and gamma-adducin.
Matou-Nasri S; Gaffney J; Kumar S; Slevin M
Int J Oncol; 2009 Oct; 35(4):761-73. PubMed ID: 19724912
[TBL] [Abstract][Full Text] [Related]
30. A requirement for the CD44 cytoplasmic domain for hyaluronan binding, pericellular matrix assembly, and receptor-mediated endocytosis in COS-7 cells.
Jiang H; Peterson RS; Wang W; Bartnik E; Knudson CB; Knudson W
J Biol Chem; 2002 Mar; 277(12):10531-8. PubMed ID: 11792695
[TBL] [Abstract][Full Text] [Related]
31. The hyaluronan receptors CD44 and Rhamm (CD168) form complexes with ERK1,2 that sustain high basal motility in breast cancer cells.
Hamilton SR; Fard SF; Paiwand FF; Tolg C; Veiseh M; Wang C; McCarthy JB; Bissell MJ; Koropatnick J; Turley EA
J Biol Chem; 2007 Jun; 282(22):16667-80. PubMed ID: 17392272
[TBL] [Abstract][Full Text] [Related]
32. Syndecan-1 Depletion Has a Differential Impact on Hyaluronic Acid Metabolism and Tumor Cell Behavior in Luminal and Triple-Negative Breast Cancer Cells.
Valla S; Hassan N; Vitale DL; Madanes D; Spinelli FM; Teixeira FCOB; Greve B; Espinoza-Sánchez NA; Cristina C; Alaniz L; Götte M
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070901
[TBL] [Abstract][Full Text] [Related]
33. Hyaluronan-mediated CD44 interaction with p300 and SIRT1 regulates beta-catenin signaling and NFkappaB-specific transcription activity leading to MDR1 and Bcl-xL gene expression and chemoresistance in breast tumor cells.
Bourguignon LYW; Xia W; Wong G
J Biol Chem; 2009 Jan; 284(5):2657-2671. PubMed ID: 19047049
[TBL] [Abstract][Full Text] [Related]
34. Hyaluronan-CD44 interaction with leukemia-associated RhoGEF and epidermal growth factor receptor promotes Rho/Ras co-activation, phospholipase C epsilon-Ca2+ signaling, and cytoskeleton modification in head and neck squamous cell carcinoma cells.
Bourguignon LY; Gilad E; Brightman A; Diedrich F; Singleton P
J Biol Chem; 2006 May; 281(20):14026-40. PubMed ID: 16565089
[TBL] [Abstract][Full Text] [Related]
35. Insights into the structural perturbations of spliced variants of CD44: a modeling and simulation approach.
Patel S; Shaikh F; Devaraji V; Radadiya A; Shah K; Shah A; Rawal R
J Biomol Struct Dyn; 2017 Feb; 35(2):354-367. PubMed ID: 26766750
[TBL] [Abstract][Full Text] [Related]
36. CD44 splice variant (CD44v3) promotes progression of urothelial carcinoma of bladder through Akt/ERK/STAT3 pathways: novel therapeutic approach.
Anand V; Khandelwal M; Appunni S; Gupta N; Seth A; Singh P; Mathur S; Sharma A
J Cancer Res Clin Oncol; 2019 Nov; 145(11):2649-2661. PubMed ID: 31529191
[TBL] [Abstract][Full Text] [Related]
37. CD44 interaction with tiam1 promotes Rac1 signaling and hyaluronic acid-mediated breast tumor cell migration.
Bourguignon LY; Zhu H; Shao L; Chen YW
J Biol Chem; 2000 Jan; 275(3):1829-38. PubMed ID: 10636882
[TBL] [Abstract][Full Text] [Related]
38. [CD44 variant increases the invasive ability of human breast cancer cell line MCF-7 cells].
Fang XJ; Xu WL; Gong JL; Chen C; Fang LL; Chen QY
Zhonghua Zhong Liu Za Zhi; 2010 Jan; 32(1):22-8. PubMed ID: 20211062
[TBL] [Abstract][Full Text] [Related]
39. Transforming growth factor-β1 (TGF-β1)-stimulated fibroblast to myofibroblast differentiation is mediated by hyaluronan (HA)-facilitated epidermal growth factor receptor (EGFR) and CD44 co-localization in lipid rafts.
Midgley AC; Rogers M; Hallett MB; Clayton A; Bowen T; Phillips AO; Steadman R
J Biol Chem; 2013 May; 288(21):14824-38. PubMed ID: 23589287
[TBL] [Abstract][Full Text] [Related]
40. A Ferulic Acid Derivative FXS-3 Inhibits Proliferation and Metastasis of Human Lung Cancer A549 Cells via Positive JNK Signaling Pathway and Negative ERK/p38, AKT/mTOR and MEK/ERK Signaling Pathways.
Yue SJ; Zhang PX; Zhu Y; Li NG; Chen YY; Li JJ; Zhang S; Jin RY; Yan H; Shi XQ; Tang YP; Duan JA
Molecules; 2019 Jun; 24(11):. PubMed ID: 31181779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
